IL133053A0 - Local delivery of long lasting therapeutic agents - Google Patents

Local delivery of long lasting therapeutic agents

Info

Publication number
IL133053A0
IL133053A0 IL13305399A IL13305399A IL133053A0 IL 133053 A0 IL133053 A0 IL 133053A0 IL 13305399 A IL13305399 A IL 13305399A IL 13305399 A IL13305399 A IL 13305399A IL 133053 A0 IL133053 A0 IL 133053A0
Authority
IL
Israel
Prior art keywords
therapeutic agents
long lasting
local delivery
lasting therapeutic
delivery
Prior art date
Application number
IL13305399A
Original Assignee
Conjuchem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conjuchem Inc filed Critical Conjuchem Inc
Publication of IL133053A0 publication Critical patent/IL133053A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13305399A 1998-03-23 1999-03-23 Local delivery of long lasting therapeutic agents IL133053A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7897498P 1998-03-23 1998-03-23
US8635298P 1998-05-20 1998-05-20
US8620598P 1998-05-21 1998-05-21
US10739198P 1998-11-06 1998-11-06
PCT/US1999/006344 WO1999048536A2 (en) 1998-03-23 1999-03-23 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo

Publications (1)

Publication Number Publication Date
IL133053A0 true IL133053A0 (en) 2001-03-19

Family

ID=27491437

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13305399A IL133053A0 (en) 1998-03-23 1999-03-23 Local delivery of long lasting therapeutic agents

Country Status (6)

Country Link
EP (1) EP1042003A1 (en)
JP (1) JP2002512640A (en)
AU (1) AU748496B2 (en)
CA (1) CA2291066A1 (en)
IL (1) IL133053A0 (en)
WO (1) WO1999048536A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
ATE420628T1 (en) 1993-07-19 2009-01-15 Angiotech Pharm Inc ANTI-ANGIogenic AGENTS AND METHODS OF USE THEREOF
EP1264840B1 (en) 1999-05-17 2009-09-23 ConjuChem Biotechnologies Inc. Long lasting fusion peptide inhibitors of viral infection
WO2000069911A1 (en) 1999-05-17 2000-11-23 Conjuchem, Inc. Long lasting insulinotropic peptides
US6514500B1 (en) 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
CA2373252C (en) * 1999-05-17 2007-08-07 Conjuchem Inc. Long lasting anti-angiogenic peptides
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
DK1105409T3 (en) * 1999-05-17 2006-07-03 Conjuchem Inc Protection of endogenous therapeutic peptides from peptidase activity by conjugation with blood components
US6849714B1 (en) 1999-05-17 2005-02-01 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
US7144854B1 (en) 1999-09-10 2006-12-05 Conjuchem, Inc. Long lasting anti-angiogenic peptides
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
DE19926154A1 (en) * 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Process for the preparation of an injectable pharmaceutical preparation
US6706892B1 (en) 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
EP1889639A3 (en) * 1999-09-07 2008-04-09 ConjuChem Biotechnologies Inc. Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
JP2003508501A (en) * 1999-09-07 2003-03-04 コンジュケム,インコーポレーテッド Pulmonary delivery for biological binding
US7090851B1 (en) 1999-09-10 2006-08-15 Conjuchem Inc. Long lasting fusion peptide inhibitors of viral infection
US6380405B1 (en) * 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6541508B2 (en) 1999-09-13 2003-04-01 Nobex Corporation Taxane prodrugs
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
JP2004520395A (en) 2001-02-02 2004-07-08 コンジュケム,インコーポレーテッド Long-lasting growth hormone releasing factor derivative
DE60226702D1 (en) 2001-02-16 2008-07-03 Conjuchem Biotechnologies Inc LONG ACTING GLUCAGON-SIMILAR PEPTIDE-2 FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS
DE60229677D1 (en) 2001-05-31 2008-12-11 Conjuchem Biotechnologies Inc Long acting fusion peptide inhibitors against HIV infection
JP4668510B2 (en) * 2001-09-29 2011-04-13 持田製薬株式会社 Pharmaceutical composition for local hemostasis in a flexible container
US20080039532A1 (en) * 2004-05-06 2008-02-14 Dominique Bridon Compounds For Specific Viral Target
BRPI0515427A (en) * 2004-09-21 2008-07-22 Advanced Medical Optics Inc viscoelastic solution or gel formulation, and methods of treating a body site with these

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883650A (en) * 1988-04-13 1989-11-28 Albert Einstein College Of Medicine - Of Yeshiva University Radioidohippuric acid ester, a conjugate thereof, and methods of making the same
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
JPH04364200A (en) * 1991-06-10 1992-12-16 Unitika Ltd Cell adhesive albumin
IL108388A0 (en) * 1993-01-21 1994-04-12 Harvard College Amplified direction of effector groups to specific target cells in an animal
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
DE19505960A1 (en) * 1995-02-21 1996-08-22 Deutsches Krebsforsch Conjugate for the individual dosage of drugs
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
ES2173641T3 (en) * 1997-11-07 2002-10-16 Conjuchem Inc COMPOSITION OF OPIACE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES.

Also Published As

Publication number Publication date
WO1999048536A2 (en) 1999-09-30
JP2002512640A (en) 2002-04-23
AU3452799A (en) 1999-10-18
CA2291066A1 (en) 1999-09-30
EP1042003A1 (en) 2000-10-11
AU748496B2 (en) 2002-06-06
WO1999048536A3 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
IL133053A0 (en) Local delivery of long lasting therapeutic agents
GB9820113D0 (en) Therapeutic agents
AU1403199A (en) Local delivery of therapeutic agents
EP1017379A4 (en) Therapeutic compositions
GB9708484D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
GB9711753D0 (en) Therapeutic agents
GB9808663D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
ZA98968B (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9815317D0 (en) Therapeutic agents